LISCure Biosciences Co.
Latest round
- Series C
Last raised
- Nov 2022
Total raised
- $30M
Investors
- 16
About LISCure Biosciences Co.
, Ltd., Ltd. develops therapeutics targeting various medical conditions. The company was established by HS Chin, who has a history of founding successful ventures.LISCure Biosciences specializes in developing innovative therapeutics through its core offerings of injectable bacteria-mediated cancer immunotherapy and oral microbiome therapeutics. The company operates on its proprietary LMT (LISCure Microbiology-based Technology) platform, which is integral for discovering and analyzing microorganism-based drug candidates. Targeting significant unmet medical needs, LISCure's product pipeline includes therapies aimed at conditions such as non-alcoholic steatohepatitis (NASH), cholestatic liver disease, autoimmune diseases, and various solid tumors, with advancements in microbiome therapeutics for neurological conditions like Parkinson’s and Alzheimer’s diseases.LISCure Biosciences generates revenue primarily through partnerships and collaborations with research institutions and through the eventual commercialization of its therapeutics. The company’s revenue model is structured around B2B transactions with healthcare providers, research organizations, and pharmaceutical companies, focusing on the development and licensing of its drug candidates, particularly those that attain regulatory approvals., Ltd. The company plans to expand its therapeutic offerings and enter new markets, focusing on regions including North America and Europe, to broaden its impact in the biopharmaceutical sector.
Who invested in LISCure Biosciences Co.
16 investors across 3 rounds
See all investors in LISCure Biosciences Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about LISCure Biosciences Co.
Who invested in LISCure Biosciences Co.?
LISCure Biosciences Co. has 16 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has LISCure Biosciences Co. raised?
LISCure Biosciences Co. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did LISCure Biosciences Co. last raise money?
LISCure Biosciences Co.'s most recent round on record is a Series C, in Nov 2022.
What does LISCure Biosciences Co. do?
LISCure Biosciences Co. is a biotechnology company.
Where is LISCure Biosciences Co. headquartered?
LISCure Biosciences Co. is headquartered in Seongnam, South Korea.
Which VCs invest in companies like LISCure Biosciences Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at LISCure Biosciences Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like LISCure Biosciences Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.